Clinical Cancer Research | March 2026
PSMA Imaging and CTCs Reveal Heterogeneity in Prostate Cancer
This study investigates PSMA expression heterogeneity in metastatic prostate cancer, showing that reduced PSMA-positive circulating tumor cells correlate with longer progression-free survival despite discordant imaging results.